


Healthcare News Roundup: Mergers
HSMN NewsFeed - 19 Apr 2010
Myriad Pharmaceuticals Announces Termination of Merger Agreement With Javelin Pharmaceuticals
Myriad Pharmaceuticals Announces Termination of Merger Agreement With Javelin Pharmaceuticals
HSMN NewsFeed - 12 Apr 2010
Myriad Pharmaceuticals Receives Notice of Javelin's Intent to Terminate Merger Agreement
Myriad Pharmaceuticals Receives Notice of Javelin's Intent to Terminate Merger Agreement
HSMN NewsFeed - 12 Apr 2010
Javelin Pharmaceuticals Delivers Notice of Intent to Terminate Merger Agreement with Myriad Pharmaceuticals
Javelin Pharmaceuticals Delivers Notice of Intent to Terminate Merger Agreement with Myriad Pharmaceuticals
HSMN NewsFeed - 22 Mar 2010
Given Imaging Signs Definitive Agreement to Acquire Sierra Scientific Instruments
Given Imaging Signs Definitive Agreement to Acquire Sierra Scientific Instruments
HSMN NewsFeed - 19 Mar 2010
Astellas Announces Changes to Director Nominees for Election to OSI Pharmaceuticals' Board of Directors
Astellas Announces Changes to Director Nominees for Election to OSI Pharmaceuticals' Board of Directors
HSMN NewsFeed - 12 Mar 2010
Manhattan Pharmaceuticals Completes Merger Transaction With Ariston Pharmaceuticals
Manhattan Pharmaceuticals Completes Merger Transaction With Ariston Pharmaceuticals
HSMN NewsFeed - 9 Mar 2010
Orthopaedic Synergy, Inc. Announces Letter of Intent to Acquire Praxim, SA
Orthopaedic Synergy, Inc. Announces Letter of Intent to Acquire Praxim, SA
HSMN NewsFeed - 5 Mar 2010
La Jolla Pharmaceutical Announces Termination of Merger Agreement with Adamis Pharmaceuticals
La Jolla Pharmaceutical Announces Termination of Merger Agreement with Adamis Pharmaceuticals
HSMN NewsFeed - 3 Mar 2010
La Jolla Pharmaceutical Announces Delisting from Nasdaq and Failure to Get Stockholder Vote for Merger
La Jolla Pharmaceutical Announces Delisting from Nasdaq and Failure to Get Stockholder Vote for Merger
HSMN NewsFeed - 2 Mar 2010
OSI Pharmaceuticals Board of Directors to Review Astellas' Unsolicited Tender Offer
OSI Pharmaceuticals Board of Directors to Review Astellas' Unsolicited Tender Offer
HSMN NewsFeed - 1 Mar 2010
OSI Pharmaceuticals Confirms Receipt of Unsolicited Proposal From Astellas Pharma
OSI Pharmaceuticals Confirms Receipt of Unsolicited Proposal From Astellas Pharma
HSMN NewsFeed - 1 Mar 2010
Astellas Pharma Inc. Offers to Acquire OSI Pharmaceuticals for $52.00 Per Share in Cash
Astellas Pharma Inc. Offers to Acquire OSI Pharmaceuticals for $52.00 Per Share in Cash
HSMN NewsFeed - 1 Mar 2010
Merck KGaA and Millipore Announce Transaction - Video Interview with Merck CEO
Merck KGaA and Millipore Announce Transaction - Video Interview with Merck CEO
